371 studies found for:    Open Studies | "Multiple Sclerosis"
Show Display Options
Rank Status Study
21 Unknown  Neurocognitive Changes in Patients With Remitting Relapsing Multiple Sclerosis Treated With Natalizumab
Conditions: Multiple Sclerosis;   Cognitive Impairment
22 Unknown  Worms for Immune Regulation of Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Biological: Hookworm larvae;   Biological: Placebo
23 Recruiting ACTH for Fatigue in Multiple Sclerosis Patients
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Drug: ACTH;   Drug: Placebo
24 Recruiting Double Blind Placebo-Controlled Phase I/II Clinical Trial of Idebenone in Patients With Primary Progressive Multiple Sclerosis (IPPoMS)
Condition: Primary Progressive Multiple Sclerosis
Intervention: Drug: Idebenone
25 Unknown  The Effects of Aerobics Training on Balance in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Other: Non Impact Aerobics;   Other: Passive : lecture series
26 Unknown  A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Avonex and Topamax
27 Recruiting EMISEP : Early Spinal Cord Lesions and Late Disability in Relapsing Remitting Multiple Sclerosis Patients
Condition: Multiple Sclerosis
Interventions: Device: spinal cord MRI follow-up;   Other: clinical follow-up;   Other: brain MRI follow-up
28 Recruiting Endpoint Calibration for a Phase 2 Study of Lisinopril in Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Procedure: Multiple Sclerosis Functional Composite;   Procedure: Mobile Multiple Sclerosis Functional Composite
29 Unknown  Cognitive Disability and Quality of Life of Patients Suffering From Multiple Sclerosis and Treatment With Immunosuppressant
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention: Other: Neuropsychological assessment
30 Recruiting A Study of Rebif® in Subjects With Relapsing Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention: Drug: Rebif®
31 Unknown  Lubiprostone in Patients With Multiple Sclerosis Associated Constipation
Conditions: Multiple Sclerosis;   Constipation
Interventions: Drug: Lubiprostone;   Drug: Placebo
32 Recruiting Observational Study of Rebismart®2.0 + MSdialog™ in Subjects With Remitting Multiple Sclerosis (ADHERQOL)
Condition: Multiple Sclerosis, Relapsing-remitting
Interventions: Device: RebiSmart®2.0;   Device: MSdialog™
33 Unknown  A Study of MSDx Complex 1 as a Marker for Therapy Response in Multiple Sclerosis
Condition: Relapsing Remitting Multiple Sclerosis
Intervention: Other: MSDX Complex-1 Biomarker test
34 Not yet recruiting A Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Biological: NeuroVax;   Biological: IFA Incomplete Freund's Adjuvant
35 Recruiting Safety and Efficacy Study of MIS416 to Treat Secondary Progressive Multiple Sclerosis
Condition: Secondary Progressive Multiple Sclerosis
Interventions: Biological: MIS416;   Drug: Saline
36 Recruiting Oral Prednisone Taper Versus Placebo for the Treatment of Acute Relapses in Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Prednisone;   Drug: Placebo
37 Recruiting MEsenchymal StEm Cells for Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Mesenchymal stem cells;   Drug: Suspension media
38 Not yet recruiting Multiple Sclerosis-Collaborative Approach to Rehabilitation Effectiveness Study
Conditions: Multiple Sclerosis;   Pain;   Depression
Intervention: Behavioral: Collaborative Care (CC)
39 Recruiting Multi-Center Study Safety of Adipose Derived Mesenchymal Stem Cells for the Treatment of Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Biological: Autologous adipose derived mesenchymal cells
40 Not yet recruiting Proof of Concept Study Evaluating RNS60 in the Treatment of Relapsing Remitting Multiple Sclerosis
Condition: Relapsing Remitting Multiple Sclerosis
Interventions: Drug: RNS60 125 ml;   Drug: RNS60 250 ml;   Drug: Interferon beta 1a

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years